Dataset from A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Exenatide Twice Daily in Subjects With Type 2 Diabetes Mellitus
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009934
下载链接
链接失效反馈官方服务：
资源简介：
To compare the effect on glycemic control (HbA1c) of exenatide suspension administered once
weekly to that achieved by exenatide administered twice daily for 28 weeks in subjects with
type 2 diabetes mellitus.
To examine the long-term (52 weeks of treatment) safety and effect on glucose control of
exenatide suspension administered once weekly in subjects with type 2 diabetes mellitus.
创建时间：
2025-07-06
